$PG

Evercore ISI upgrades Procter & Gamble stock rating on sales outlook

Evercore ISI upgraded Procter & Gamble (PG) to Outperform, raising its price target to $166.00. The firm increased its Q1 FY2027 organic sales growth estimate to 3% and expects 4% growth by the end of FY2027. PG's stock trades at a P/E ratio of 22 with a market cap of $339 billion. Moody's upgraded its outlook for PG to positive, citing strong cash flow and earnings growth. Other analysts have also raised price targets and reaffirmed positive ratings.

Original reporting
Published Oct 6, 2026, 10:48 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PG
Bullish
high confidence
Mentioned
$PG
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PGBullishMed
01

Why it matters

The upgrade could attract new buying interest and support the stock near its 52‑week high.

02

Market read

A fresh analyst upgrade for a $339 B market‑cap consumer staple provides a tangible trading catalyst.

03

What to watch

Potential headwinds from oil and logistics cost pressures noted in the report.

Relevance 7/10Novelty 7/10Timing: today

Background

Evercore ISI raised its organic sales growth estimate for PG and highlighted operating leverage benefits.

Company-level read

Ticker impact

$PGBullishHigh confidence
Context

Evercore ISI upgraded Procter & Gamble to Outperform and raised the price target to $166.

Expected impact

likely upward pressure as investors price in the new target.

Evidence & confidence

The upgrade is the first report of a higher target for a large‑cap consumer staple, providing a fresh catalyst.

Market effects

The upgrade may lift sentiment across the consumer staples sector.

U.S. market may see modest buying in consumer goods stocks.

Limited to U.S. equities; no direct global impact.

Counterpoint

Some investors may view the upgrade as already priced in, limiting upside.

Key entities

  • Evercore ISI

    Equity research firm issuing the upgrade.

  • Procter & Gamble

    Consumer staples giant receiving the upgrade.

Related articles

$PGLow

Access Proposal at Procter & Gamble

Institutional Shareholder Services (ISS) recommended Procter & Gamble (P&G) shareholders vote 'for' a proposal opposed by the company's board. The proposal, brought by the National Legal and Policy Center (NLPC), aims to preserve shareholder access rights. P&G argues the vote is premature, as the SEC has proposed repealing the rule enabling such proposals. The vote is scheduled for October 13.

$LENHighAI 8/10

Stocks making the biggest moves premarket: Constellation Energy, Option Care Health, Lennar, P&G and more

Constellation Energy (CEG) surged 6% after Google's $4.3B power agreement. Option Care Health (OPK) rose 20% on potential $5B acquisition by McKesson (MCK) and Clayton Dubilier. Lennar (LEN) gained 1.5% after Berkshire Hathaway (BRK.A) disclosed a 2.4M share purchase. NeoGenomics (NEO) climbed 5% on revenue beat and succession plan. AMD (AMD) rose 2% on Citi's $800 price target. P&G (PG) up 1.2% after Evercore ISI upgrade. Corteva (CTVA) gained 3% on JPMorgan upgrade.

$MSFTMed

BLOOMBERG: Shareholders Pressure Companies to Keep Proposals at Annual Meetings

The SEC proposes ending the rule allowing shareholders to submit proposals at annual meetings. Investors, including the National Legal and Policy Center, have pushed back. Microsoft agreed to keep accepting proposals for one year. Procter & Gamble and Oracle will vote on similar proposals in October and November. Smaller shareholders rely on this rule to voice concerns, unlike large firms that can directly contact executives.

$PGHighAI 9/10

Market Moves: Supplement industry deals of Q3 2026

Procter & Gamble agreed to acquire Thorne for $3.8B, expanding its health portfolio. Yellow Wood Partners bought Nestlé’s Holistic Health for $1B. Other deals include Fullscript’s majority stake sale, Wellma’s acquisition of Virun, and Kirin’s purchase of Jamieson Wellness for C$2.5B. Transactions highlight trends in premium wellness, supply chain control, and global expansion.